Jason McDevitt serves as Director of the Technology Transfer Office. Dr. McDevitt received a Ph.D. in chemistry from MIT, and a BA in chemistry from Yale. He is also a registered patent agent.

After receiving his doctorate, Dr. McDevitt held various positions in central research and business development in the chemical, biotech, and consumer products industries. He subsequently worked in the technology licensing offices of the University of Georgia and Emory University prior to joining W&M in July, 2004.

Dr. McDevitt is an inventor on 27 issued United States patents, in addition to numerous patents pending covering a wide range of fields including pharmaceuticals, medical devices, polymers, catalysts, textiles, and consumer products. He is a co-founder and CEO of Extinction Pharmaceuticals, Inc., a startup company that is developing a novel approach to treatment of anxiety disorders and other afflictions exacerbated by anxiety.